Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab

Overview of attention for article published in The Journal of Allergy and Clinical Immunology, November 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 13 news outlets
twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 32 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,930 followers.

RT @DDNewsOnline: #Transcriptomics shows @galderma’s #nemolizumab reduces #inflammation in #PrurigoNodularis by reducing IL-31 Anti-IL-31R…

Reply Repost Favourite

Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab https://t.co/JjaSDpPYjM

Reply Repost Favourite